Imaging machine for the brain

Actinogen reports busy 6 months as development of Xanamem molecule ramps up

Actinogen Medical Ltd said it had pared back net losses in the 6 months to December…
A toilet in an abandoned spot

Immuron progresses development of traveller’s diarrhea drug Travelan

Immuron Ltd has presented a Clinical Study Report to the US Food and Drug Administration following…